Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,964.00    26.00 (0.88%)
Bid:
2,944.00
Ask:
2,948.00
Spread: 4.00 (0.136%)
Market Cap: £1.63b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Disposal

18 Nov 2016 07:00

RNS Number : 5211P
Oxford Instruments PLC
18 November 2016
 

Release date: 18 November 2016

Oxford Instruments plc

Disposal of Oxford Instruments Superconducting Wire LLC ("OST")

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces the disposal of Oxford Instruments Superconducting Wire LLC ("OST") to Bruker Energy and Supercon Technologies Inc ("BEST"), a subsidiary of Bruker Corporation, for a consideration of $17.5 million, payable in cash. In the transaction, BEST has acquired the entire share capital of OST from Oxford Instruments.

 

OST supplies world-leading superconducting wire for use in MRI scanners and other medical and scientific applications; it is located in Carteret, New Jersey, USA. The business was previously part of Oxford Instruments' Industrial Products division.

 

In the year ended 31 March 2016, OST had revenues of £42.4 million and achieved an operating profit of £3.4 million. In the six months to 30 September 2016, OST had revenues of £19.1 million and achieved an operating profit of £1.1 million. The gross assets of OST at 31 March 2016 were £19.0 million.

Oxford Instruments has previously reported challenges within the superconducting wire markets due primarily to pricing pressures exerted by the MRI system manufacturers and reduced demand for wire from OEM customers. The disposal represents a further step in the Group's strategy of actively managing its portfolio.

Ian Barkshire, Chief Executive of Oxford Instruments said "After a comprehensive review of our portfolio, the Board has determined that our Superconducting Wire business is no longer core to the Group's long-term strategic vision. The divestment will allow increased focus across the Group on our chosen market segments and the cash proceeds will enable us to reduce our net debt, in line with our strategy to deliver enhanced shareholder value.

"OST is a high quality business and we believe that as part of BEST, it will benefit from the realisation of synergies and the scale of BEST's expertise in low-temperature superconductors. This will ensure that the business continues to provide customers with the highest quality products and fosters the exceptional skills of its talented workforce."

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Ian Barkshire, Chief Executive

Gavin Hill, Group Finance Director

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst/Jamie Ricketts

 

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

 

The first technology business to be spun out from Oxford University, Oxford Instruments is now a global company and is listed on the London Stock Exchange (OXIG). Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect.

 

This involves the combination of core technologies in areas such as low temperature and high magnetic field environments; Nuclear Magnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

 

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISDXBDBDXBBGLR
Date   Source Headline
9th Feb 20267:00 amPRNTransaction in Own Shares
6th Feb 20267:00 amPRNTransaction in Own Shares
5th Feb 20267:00 amPRNTransaction in Own Shares
4th Feb 20267:00 amPRNTransaction in Own Shares
3rd Feb 20267:00 amPRNTransaction in Own Shares
2nd Feb 20262:53 pmPRNTotal Voting Rights
2nd Feb 20267:59 amPRNTransaction in Own Shares
30th Jan 20267:00 amPRNTransaction in Own Shares
29th Jan 20267:00 amPRNTransaction in Own Shares
28th Jan 20267:00 amPRNTransaction in Own Shares
27th Jan 20267:00 amPRNTransaction in Own Shares
26th Jan 20267:00 amPRNTransaction in Own Shares
23rd Jan 20264:26 pmPRNHolding(s) in Company
22nd Jan 20267:00 amPRNTransaction in Own Shares
21st Jan 20267:00 amPRNTransaction in Own Shares
20th Jan 20267:00 amPRNTransaction in Own Shares
19th Jan 20269:39 amPRNHolding(s) in Company
15th Jan 20267:00 amRNSTrading Update
15th Jan 20267:00 amPRNTransaction in Own Shares
14th Jan 20262:15 pmPRNHolding(s) in Company
13th Jan 20264:15 pmPRNHolding(s) in Company
13th Jan 20267:00 amPRNTransaction in Own Shares
12th Jan 20267:00 amPRNTransaction in Own Shares
9th Jan 20267:00 amPRNTransaction in Own Shares
8th Jan 20267:00 amPRNTransaction in Own Shares
7th Jan 20267:00 amPRNTransaction in Own Shares
6th Jan 20267:00 amPRNTransaction in Own Shares
2nd Jan 202612:44 pmPRNBlock listing Interim Review
2nd Jan 202612:26 pmPRNTotal Voting Rights
23rd Dec 20253:32 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:32 pmPRNDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amPRNTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amPRNTransaction in Own Shares
18th Dec 20257:00 amPRNTransaction in Own Shares
17th Dec 20253:16 pmPRNHolding(s) in Company
17th Dec 20257:00 amPRNTransaction in Own Shares
16th Dec 20257:00 amPRNTransaction in Own Shares
15th Dec 20257:00 amPRNTransaction in Own Shares
12th Dec 20257:00 amPRNTransaction in Own Shares
11th Dec 20257:00 amPRNTransaction in Own Shares
10th Dec 20257:00 amPRNTransaction in Own Shares
9th Dec 20257:00 amPRNTransaction in Own Shares
8th Dec 20252:37 pmPRNHolding(s) in Company
3rd Dec 20257:00 amPRNTransaction in Own Shares
2nd Dec 20257:00 amPRNTransaction in Own Shares
1st Dec 202510:37 amPRNTotal Voting Rights
1st Dec 20257:00 amPRNTransaction in Own Shares
28th Nov 20257:00 amPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.